1. Chiquette, E., et al. Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges. Diabetes Metab Syndr Obes, 2017. 10: p.375-383.
2: Dhankar, P., et al., Estimating Quality of Life of Patients with Lipodystrophy. Value in Health, 2015. 18(3): A292.
3: Gupta, N., et al., Clinical Features and Management of Non-HIV-Related Lipodystrophy in Children: A Systematic Review. J Clin Endocrinol Metab, 2017. 102(2): p. 363-374.
4: Kelesidis, T. et al., Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications. Ann Intern Med, 2010. 152(2): p. 93-100.
5: Akinci, B., et al., Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study from Turkey. J Clin Endocrinol Metab, 2016. 101(7): p. 2759-67.
6: Brown, R.J., et al., The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline. J Clin Endocrinol Metab, 2016. 101(12): p. 4500-4511.
7: Pope, E., et al., Childhood acquired Lipodystrophy: A retrospective study. Journal of the American Academy of Dermatology, 2006. 55(6): p. 947-950.
8: Misra, A. and A. Garg, Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature. Medicine (Baltimore), 2003. 82(2): p.-29-46.
